{"id":477082,"date":"2020-03-31T19:36:01","date_gmt":"2020-03-31T19:36:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=477082"},"modified":"2020-03-31T19:36:01","modified_gmt":"2020-03-31T19:36:01","slug":"praderwilli-syndrome-market-size-share-trend-epidemiology-market-forecast-to-2030","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/praderwilli-syndrome-market-size-share-trend-epidemiology-market-forecast-to-2030_477082.html","title":{"rendered":"Prader-Willi Syndrome Market Size, Share, Trend, Epidemiology & Market Forecast to 2030"},"content":{"rendered":"
\"Prader-Willi<\/a><\/p>\n
\n
Delveinsight Business Research<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Prader-Willi Syndrome, historical and forecasted epidemiology as well as the Prader-Willi Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<\/div>\n

The Prader-Willi Syndrome market report covers emerging drugs, current treatment practices, Prader-Willi Syndrome market share of the individual therapies, current and forecasted Prader-Willi Syndrome Market Size from 2017 to 2030 segmented by seven major markets. <\/p>\n

The report also provides detailed current Prader-Willi Syndrome treatment practice\/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. <\/p>\n

 <\/span><\/span><\/p>\n

Prader-Willi Syndrome Market Key Facts<\/span><\/strong><\/p>\n

As per the Foundation for PWS Research, the Prader-Willi Syndrome occurs in approximately one out of every 15,000 births. It affects males and females with equal frequency and affects all races and ethnicities<\/p>\n

According to DelveInsight’s estimation, the total prevalent cases of Prader Willi syndrome (PWS) were found to be ~47,000 for 7 Major Markets in the year 2017<\/p>\n

The Prader-Willi Syndrome Association (PWSA) estimates that the prevalence of PWS is approximately 1 in 12-15,000 people in the US. Using the more conservative estimate, this translates into a target population of approximately 22,000 at present which is quite low.<\/p>\n

 \"\"<\/span><\/span><\/p>\n

Visit For Sample Pages: <\/span><\/strong><\/p>\n

https:\/\/www.delveinsight.com\/sample-request\/prader-willi-syndrome-market<\/a><\/strong><\/p>\n

 <\/strong><\/p>\n

Key Benefits of Prader-Willi Syndrome Market Report<\/strong><\/p>\n

Prader-Willi Syndrome market report provides an in-depth analysis of Prader-Willi Syndrome Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.<\/span><\/p>\n

The Prader-Willi Syndrome market report will help in developing business strategies by understanding the Prader-Willi Syndrome Market trends & developments, key players and future market competition that will shape and drive the Prader-Willi Syndrome market in the upcoming years.<\/p>\n

The Prader-Willi Syndrome market report covers Prader-Willi Syndrome current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.<\/p>\n

The report provides a detailed assessment of the Prader-Willi Syndrome market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. <\/p>\n

 <\/p>\n

Prader-Willi Syndrome Market<\/span><\/a><\/strong><\/p>\n

The Prader-Willi Syndrome market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Prader-Willi Syndrome market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. <\/span><\/p>\n

 <\/span>The report gives a thorough detail of Prader-Willi Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. <\/p>\n

Prader-Willi Syndrome Epidemiology<\/a><\/strong><\/p>\n

The Prader-Willi Syndrome epidemiology section covers insights about historical and current Prader-Willi Syndrome patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.<\/span><\/p>\n

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  <\/span><\/p>\n

 <\/span><\/p>\n

Prader-Willi Syndrome Drugs Uptake and Key Market Players<\/a><\/strong><\/p>\n

Prader-Willi Syndrome Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Prader-Willi Syndrome market or expected to get launched in the market during the study period. The analysis covers Prader-Willi Syndrome market uptake by drugs; patient uptake by therapies; and sales of each drug.    <\/span><\/p>\n

Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions. Some of the emerging therapies in  <\/span>Prader-Willi Syndrome market includes <\/span>Livoletide or AZP-531, Pitolisant, LV-101, and many others<\/span><\/p>\n

Key players in <\/span>Prader-Willi Syndrome market includes <\/span>Millendo Therapeutics, Harmony Biosciences, Soleno Therapeutics, Levo Therapeutics and others.<\/span><\/p>\n

 <\/span><\/span><\/p>\n

Table of Content<\/span><\/strong><\/p>\n

1. Key Insights<\/span><\/p>\n

2. Executive Summary <\/span><\/p>\n

3. Prader-Willi Syndrome Competitive Intelligence Analysis<\/span><\/p>\n

4. Prader-Willi Syndrome Market Overview at a Glance<\/span><\/p>\n

5. Prader-Willi Syndrome Disease Background and Overview<\/span><\/p>\n

6. Prader-Willi Syndrome Patient Journey<\/span><\/p>\n

7. Prader-Willi Syndrome Epidemiology and Patient Population<\/span><\/p>\n

8. Prader-Willi Syndrome Treatment Algorithm, Current Treatment, and Medical Practices<\/span><\/p>\n

9. Prader-Willi Syndrome Unmet Needs<\/span><\/p>\n

10. Key Endpoints of Prader-Willi Syndrome Treatment<\/span><\/p>\n

11. Prader-Willi Syndrome Marketed Products<\/span><\/p>\n

12. Prader-Willi Syndrome Emerging Therapies<\/span><\/p>\n

13. Prader-Willi Syndrome Seven Major Market Analysis<\/span><\/p>\n

14. Attribute Analysis<\/span><\/p>\n

15. Prader-Willi Syndrome Market Outlook (7 major markets)<\/span><\/p>\n

16. Prader-Willi Syndrome Access and Reimbursement Overview<\/span><\/p>\n

17. KOL Views on the Prader-Willi Syndrome Market.<\/span><\/p>\n

18. Prader-Willi Syndrome Market Drivers<\/span><\/p>\n

19. Prader-Willi Syndrome Market Barriers<\/span><\/p>\n

20. Appendix<\/span><\/p>\n

21. DelveInsight Capabilities<\/span><\/p>\n

22. Disclaimer<\/span><\/p>\n

 <\/span><\/span><\/p>\n

About <\/span>DelveInsight<\/a><\/strong><\/p>\n

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.<\/span><\/p>\n

 <\/span><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> DelveInsight Business Research LLP<\/a>
Contact Person:<\/strong> Anuj Rawat
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +919650213330
Address:<\/strong>304 S. Jones Blvd #2432
City:<\/strong> Albany
State:<\/strong> New York
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.delveinsight.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Delveinsight Business Research DelveInsight’s “Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Prader-Willi Syndrome, historical and forecasted epidemiology as well as the Prader-Willi Syndrome market trends in the United States, EU5 (Germany, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,417,403,404],"tags":[],"class_list":["post-477082","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Marketing-Sales","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/477082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=477082"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/477082\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=477082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=477082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=477082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}